Aua Capital Management, LLC Amphastar Pharmaceuticals, Inc. Transaction History

Aua Capital Management, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$27.93 - $31.27 $363 - $406	-13 Reduced 31.71%	28 $0
Q2 2022 Aug 11, 2022	BUY	$29.79 - $42.29 $327 - $465	11 Added 36.67%	41 $1,000
Q4 2021 Feb 11, 2022	BUY	$18.14 - $23.29 $126 - $163	7 Added 30.43%	30 $1,000
Q3 2021 Nov 09, 2021	SELL	$17.83 - $21.49 $142 - $171	-8 Reduced 25.81%	23 $0
Q1 2021 May 11, 2021	SELL	$17.21 - $20.65 $172 - $206	-10 Reduced 24.39%	31 $1,000
Q4 2020 Feb 09, 2021	SELL	$17.76 - $21.24 $408 - $488	-23 Reduced 35.94%	41 $1,000
Q3 2020 Nov 12, 2020	BUY	$17.99 - $22.22 $1,151 - $1,422	64 New	64 $1,000

286

34.9M

74.3K

22.3K

Ticker AMPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,015,200
Market Cap $1.92B
Description
Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...

Get notified when there are updates to the investment portfolio of Aua Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Aua Capital Management, LLC with notifications on news.